Scott Tarriff, CEO at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 49,950 shares at $50.15 ($2.5M) on 2019-04-01, disclosed to the SEC on 2019-04-03.
Open-market sale of $2.5M EGRX by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.15 | 24,975 | $1.3M | 50.0% |
| 2 | $50.15 | 24,975 | $1.3M | 50.0% |
| Total | $50.15 avg | 49,950 | $2.5M | 100% |
| Filing → |
| EGRX | SELL | 2023-05-18 | $300K | — | Filing → |
| EGRX | SELL | 2023-05-15 | $1.2M | — | Filing → |
| EGRX | SELL | 2019-03-04 | $1.9M | — | Filing → |